Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Narrowband UVB plus topical tacrolimus versus narrowband UVB alone in vitiligo
IRCT201606239014N103Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tacrolimus in Vitiligo (2 arms), sponsored by Hamadan University of Medical Sciences. Started Jul 2016; status: completed.
02
Drugs
tacrolimus
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT201606239014N103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201606239014N103.